My name is Siena Palicke, and I graduated from Texas A&M University with a B.S. in Microbiology. I will begin medical school in Fall 2026, and my long-term goal is to become a physician who contributes to cancer research, specifically research that leads to earlier detection and more effective treatments for aggressive cancers like triple negative breast cancer. My interest in research began during my undergraduate work in a Clostridioides difficile laboratory. I studied how C. diff spores interact with gut epithelial cells, ran wet-lab assays, and supported a peptide microarray project aimed at identifying key protein-binding sites. One semester, I became animal-handler certified to assist with our lab's mouse trials. By the time I completed my degree, I had enough data to present my work at several conferences, which showed me the impact that careful, methodical scientific effort can have. More than anything, it taught me how research directly translates to real human outcomes. As I began preparing for medical school, breast cancer became personal. My grandma was diagnosed with Stage IV breast cancer several years ago, and my family braced for the worst. Against all odds, she survived. Watching her fight taught me how fragile and precious time can be, and how deeply families depend on advancements in detection, treatment, and research. I remembered getting screened on multiple occassions as a child for any breast abnormalities, and this strengthened my resolve to engage in breast cancer research. My grandma's survival wasn’t luck alone; it was the result of decades of scientific progress, clinical trials, and researchers who refused to give up on finding better therapies. Knowing that research helped give my grandma more life is what motivates me to be part of that progress for other families. That personal experience is also what drew me to Dr. Nova Grace Hinman Weinstein’s story. Her life, her resilience, and the legacy she leaves behind highlight how urgently we need young researchers committed to understanding and treating aggressive cancers like triple negative breast cancer. I want to honor both her memory and the women like my grandmother whose lives depend on continued scientific advancement. My research goal is to contribute to improving diagnostic tools and identifying earlier, more precise markers for aggressive breast cancers. During medical school, I plan to join a lab focused on molecular oncology or tumor-microenvironment research and build on the technical foundation I developed in my undergraduate lab. Long-term, I hope to work at the intersection of clinical medicine and research, bridging the gap between the bench and the bedside so discoveries translate into real options for patients. What motivates me most is knowing that progress doesn’t come from one breakthrough—it comes from thousands of careful contributions made by people committed to finding answers. That is the mindset I want to bring into oncology research. I hope to dedicate my training, curiosity, and medical career to creating the kind of advancements that gave my grandmother more time and that will one day offer more hope to families facing diagnoses like Dr. Hinman Weinstein’s.